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Summary.-Strain BALB/c female mice bearing syngeneic implants of 2 mammary
adenocarcinomata were treated with MER, x-irradiation or both. MER was adminis-
tered either subcutaneously at a site contralateral to the neoplastic growth or both
into such a site and directly at the tumour location. None of the treatments effected
cures but many of the treated animals survived significantly longer than did the
saline injected controls. There was no evidence that introduction of MER into, or
directly adjacent to, a tumour is a generally more efficacious route of administration
than application at only a distal site and there was, indeed, the strong contrary
impression that distal treatment alone bestowed survival protection more often and
to a greater extent. In no instance was there a shortening of survival time following
administration of MER at a location away from the tumour implant.
THE MER fraction of phenol killed,
acetone washed tubercle bacilli has been
shown to be a powerful modulator of
immunological responsiveness (Ben-
Efraim, Constantini-Sourojon and Weiss,
1973; Ben Efraim et al., 1974; Gery et al.,
1974; Kuperman, Feigis and Weiss, 1973;
Weiss, 1972; WeissandYashphe, 1973) and
capable ofmoderate to marked therapeutic
action when administered alone or together
with x-irradiation and/or chemotherapy
against a variety of solid and leukaemic
neoplasms of experimental animals and
man (Haran-Ghera and Weiss, 1973;
Izak et al., 1974; Moertel et al., 1975;
Richman, 1975; Weiss et al., 1975; Yron
et al., 1973, 1975). It appeared from
preliminary experiments that distal
administration of this agent to animals
bearing solid tumour implants is as
efficacious as, or even more efficacious
than, injection directly into the tumour
mass (Yron et al., 1973, 1975). The
question of route of treatment of neoplas-
tic disease by immunological means
deserves further experimental study and
we have, accordingly, initiated a series of
experiments in inbred mice and guinea-
pigs to determine the relative therapeutic
capability of MER against solid tumour
isografts, when treatment is given into or
adjacent to the tumour and when given at
a distal subcutaneous site. The present
report describes findings in mice
challenged with syngeneic mammary
carcinomata.
MATERIALS AND METHODS
The animals and tumours employed, the
origin of the MER preparation, the design
of the experiments and means of statistical
analysis ofthe findings and all other technical
details have been described in full in the
preceding communication (Yron et al., 1975)
and need here be stated only briefly.
Animals. Young adult female mice of
the BALB/c strain raised at Hadassah
Medical School in Jerusalem were used.
Tumours.-The tumours were 2 trans-
plantable mammaryadenocarcinomata. One
arose in an outgrowth line of a hyperplasticD. COHEN, I. YRON, M. HABER, E. ROBINSON AND D. W. WEISS
alveolar mammary nodule appearing in a
hormonally hyperstimulated BALB/c female
and is designated D7T4S. The other arose
spontaneously in a multiparous BALB/cfC3H
female infected with the mammary tumour
virus (MTV). The reciprocal isogenicity of
the 2 sublines BALB/c and BALB/cfC3H
was confirmed throughout the course ofthese
experiments by the demonstrated acceptance
of second-set skin grafts exchanged between
randomly selected female animals from the
breeding colony.
MER.-The MER preparation was from
the same lot described previously (Yron et al.,
1975), prepared by Merck, Sharpe and
Dohme Research Laboratories (Rahway,
New Jersey).
Therapeutic irradiation.-A single dose of
x-irradiation was given to the tumour site
of those animals which were treated with
irradiationalone orwithirradiation andMER;
mice bearingtumour D7T4S received 2000 rad
and those with the MTV(+-) carcinoma
3000 rad.
Experimental design.-In each distinct
experiment the mice were distributed at
random into groups of 13-17 animals each
and were given subcutaneous (s.c.) implants
of living tumour tissue (ca. 1 mm3) in the
left inguinal area. Treatment xvas begun
17-21 days after implantation, when 50-70%o
of the mice in most of the groups had devel-
oped groxvths visible upon inspection of the
intact animal; the few groups in which the
number of tumour bearing animals at that
time was either smaller or greater were
excluded from the studies.
Treatment consisted of a single adminis-
tration of 0 4 mg MER, or of x-rays, or of
both adininistered at 2 different times.
Animals of groups not receiving MER at a
time when the others received this treatment
were given injections of placebo only (0.85%
sterile, pyrogen-free saline). MER was admin-
istered either by a single s.c. injection of
0-4 mg at a site contralateral to the tumour
(distal [dis] administration ), or 2 simul-
taneous injections of0-2 mg each, one directly
into the tumour area (" ta ") and one distally
s.c.
The mice were observed twice weekly for
95 days after implantation. Most of the
animals developed progressively growing
cancers at the implantation site regardless of
treatment, and many died with large tumour
masses during this period. Animals surviv-
ing tumour free at the end of the time of
observation were included in the calculation;
the few mice (less than 5%o) which died with-
out visible tumours were excluded from the
calculations.
Although none of the treatments
succeeded in preventing progressive tumour
development, many ofthe mice given irradia-
tion or MER alone or combined treatment
showed a marked slowing of tumour growth
and prolonged survival. In these as well as
in the previously reported (Yron et al., 1973,
1975) experiments with solid mammary
tumours of mice, retardation of tumour
development and prolongation of host sur-
vival were on the whole closely associated
manifestations oflimited therapeutic success.
The results oftherapy in the present study are
presented in terms of host longevity after
tumour implantation and subsequent treat-
ment, but they accordingly provide as well a
parallel indication of effects on tumour
growth rate.
Statistical analysis.-Differences in the
numbers of animals surviving at each time
of observation were analyzed by the x2 test
(two-tailed); comparisons were made between
the experimental and control groups of each
experiment and between different experi-
mental groups with each other. The results
ofthese comparisons are shown for 3 consecu-
tive periods of measurement, 50-60, 61-70
and 75-90 days after tumour implantation.
Where the differences obtained for 2 or more
observations within any one such time
period were significant, the groups are
described as differing significantly for that
period; a significant difference at only one
time of observation is not considered as
representing a significant variation for that
entire interval.
RESULTS
Figure 1 presents the findings obtained
in an initial experiment comparing the
effects of treatment with MER at a s.c.
distal site and both at such a site and in
the immediate vicinity of the neoplasms;
the agent was injected 21 days after
implantation of tumour D7T4S. Mice
receiving MER directly into the tumour
area as well as elsewhere were afforded
no protection. In contrast, treatment
with MER by distal injection only,
484INJECTION OF MER AT THE TUMOUR SITE OR AT A DISTAL LOCATION
80v
80
-:
I-
0
z
LbJ
Q-
60_
20
-35 45 55 65 75 85 95
DAYS AFTER TUMOUR IMPLANTATION
FIG. 1. Effect of different routes of MER administration on the survival of mice bearing syngeneic
implants of mammary carcinoma D7T4S.
Treatment
Days after tumour implantation
AE
Group 17 21
I MER,0-4mg,dis
-* * *-* 2 - MER, 0-2mg, dis+0 2mg, ta
---------- 3 Saline, dis Saline, dis
4 Saline, dis + ta Saline, dis + ta
Statistically significant (P < 0 05) differences: Group 1 vs Group 2, at all 3 intervals; Group
1 vs Group 3, at all 3 intervals; Group 1 vs Group 4, at 2 intervals.
bestowed significant survival protection,
both in comparison with the saline controls
and with the animals given MER into the
tumour region as well as distally.
The results of a second experiment,
with the MTV(+) carcinoma, are depicted
in Fig. 2. Here it is seen that the survival
time of mice subjected to local plus distal
introduction of MER at Day 21 after
tumour implantation again did not differ
significantly from that of either saline
control group. As before, MER adminis-
tered solely at a place removed from the
tumour effected an appreciable prolong-
ation of survival, significantly so when
compared with the survival times of mice
receiving MER at the tumour site as well
as distally, and when compared with the
controls given saline at a removed site.
However, the protection afforded by
distal MER was not significant when
compared with the survival pattern of
animals injected with saline both into the
tumour area and at a removed locus. We
have noticed in other studies that trau-
matic injury sometimes leads to a non-
specific activation of lymphoid cell and/or
macrophage cytotoxic capacity, an effect
perhaps accruing from the response to
injured and necrotic tissues, and it may be
that such reactions here reduced the
demonstrable protective activity of MER
when the comparison was with the group
receiving saline directly into the tumour
location.
The observations made in a third
experiment conducted simultaneouslywith
the second are shown in Fig. 3. Mice
given MER both distally and at the place
of transplants of the MTV(+) tumour
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FIG. 2.-Effect of different routes of MER administration on the survival of mice bearing syngeneic
implants of an MTV(+-) mammary carcinoma.
Treatment
Days after tumour implantation
Group 21 25
1 Mer, 0-4mg, dis
2 MER, 0-2mg, dis+ 0 2mg, ta
3 Saline, dis Saline, dis
4 Saline, dis + ta Saline, dis + ta
Statistically significant differences: Group 1 vs Group 2, at 1 time interval; Group 1 vs Group 3, at
1 time interval.
succumbed significantly sooner than either
of the control groups. On the other
hand, the animals treated by distal
administration only, survived significantly
longer than either those receiving some
of the MER into the tumour area or those
receiving saline at a distal s.c. site. The
distally treated MER animals also showed
some survival protection compared with
mice given saline into the tumour site and
elsewhere, but here too, this effect was
not statistically significant.
In a further experiment, the effects
of these different routes of MER intro-
duction were compared in animals receiv-
ing additional therapy by means ofx-rays.
It is seen from Fig. 4 that mice given
x-rays on Day 17 and MER s.c. on Day 21
after implantation of tumour D7T4S died
more slowly with progressively growing
cancers than the animals in any of the
other groups. The differences in survival
times between these mice and those of
both control groups and of the group
given x-rays alone were significant.
Radiation therapy by itself improved
survival significantly at one time interval
over that of animals given saline at a
distal s.c. site but not over that of animals
receiving saline into the tumour focus as
well. The combined therapeutic inter-
vention of x-rays plus MER administered
both to the tumour site and distally
effected significant survival protection
compared with both the control groups,
but did not improve the results obtained
with irradiation alone. Thus in this
experiment, combined therapy proved
superior to x-rays alone only where
treatment with MER was to a distal
location and not into the tumour region.
In a parallel experiment with the same
carcinoma in which treatment with MER
(on Day 17) preceded therapeutic irradia-
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FIG. 3.-Effect of different routes of MER administration on the survival of mice bearing syngeneic
implants of an MTV(+) mammary carcinoma.
Group
Treatment
Days after tumour implantation
I I
21 25
1 - MER, 0*4mg, dis
2 - MER, 0 2mg, dis + 0 2mg, ta
3 Saline, dis Saline, dis
4 Saline, dis + ta Saline, dis + ta
Statistically significant differences: Group 1 vs Group 2, at all 3 intervals; Group 1 V8 Group 3, at
1 interval; Group 2 vs Group 3, at 2 intervals; Group 2 Vs Group 4, at all 3 intervals.
tion (Day 21), x-rays alone exerted signi-
ficant survival prolongation effects, as did
combined irradiation-MER treatment,
regardless of the route of MER adminis-
tration. In this one experiment, however,
injection of MER both into the tumour
area and distally was slightly, but signifi-
cantly, more efficacious than introduction
of the agent at a removed s.c. locality
only. Moreover, whereas there was no
significant difference in the degree of
protection achieved by irradiation alone
and by combined treatment in which
MER was applied both distally and in the
tumour area, x-ray therapy alone was
significantly better than joint intervention
with MER injected only distally.
DISCUSSION
The tumour therapy experiments here
described were conducted with 2 mammary
carcinomata of BALB/c mice, both of
which develop rapidly and fatally in the
syngeneic hosts. Neither MER nor thera-
peutic irradiation, nor combined treat-
ment, succeeded in effecting cures. How-
ever, these modalities of intervention
often slowed the growth of the neoplasms
and prolonged the survival of the animals
commensurately.
Treatment with MER alone bestowed
significant survival protection in all of 3
experiments when the material was admin-
istered at a subcutaneous site distal from
the tumour focus. When, however, injec-
tion ofMER was both at such a distal site
and directly into the tumour location, no
protection was afforded and significantly
shortenedsurvival was seenin oneinstance.
In 2 additional experiments in which
tumour bearing mice were treated with
both MER and focal x-irradiation, therapy
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FIG. 4.-Effect of x-irradiation and MER administration by different routes on the survival of mice
bearing syngeneic implants of mammary carcinoma D7T4S.
Group 17
Treatment
Days after tumour implantation
'K- A
21
1 X-rays MER, 0-4mg, dis
* - - - - - - - - -2 X-rays Saline, dis
3 X-rays MER, 0-2mg, dis+0 2mg, ta
---------- 4 Saline, dis Saline, dis
5 Saline, dis + ta Saline, dis + ta
Statistically significant differences: Group 1 vs Group 2, at 2 intervals; Group 1 vs Group 4, at all
3 intervals; Group 1 vs Group 5, at 2 intervals; Group 2 vs Group 4, at 1 interval; Group 3 vs
Group 4, at all 3 intervals; Group 3 vs Group 5, at 2 intervals.
by irradiation alone as well as combined
therapy proved effective in survival pro-
longation. Where combined treatment
was used, significant efficacy was demon-
strated when MER administration was
only at a distal site, and also when it was
both into the tumour locality and distally.
In one of these experiments, joint treat-
ment with x-rays and MER proved
superior to irradiation alone only when
MER administration was at a site distal
to the tumour, and not when the fraction
was introduced both into the tumour
region and away from it. In the second
experiment, in which the sequence of
x-ray and MER treatment was reversed,
joint therapy was in neither instance
more effective than x-rays by themselves,
and was less beneficial than irradiation
alone when the MER component of the
combined modality was given at a distal
site.
These observations thus indicate that
in most instances MER applied solely at a
s.c. location contralateral to the tumour
implant is more likely to bestow a degree
of protection against the rapidly fatal
progression of 2 solid mammary carcino-
mata than introduction of the substance
at the tumour site as well as distally.
Although these findings do not permit
generalization as to the advantage of
introducing a nonspecific modulator of
immunological responsiveness and anti-
tumour resistance at a place removed
from aneoplastic focus, they are consis,-it
with the observations of many other
investigators that nonspecific immuno-
488
o L
2siINJECTION OF MER AT THE TUMOUR SITE OR AT A DISTAL LOCATION 489
therapy ofneoplastic disease is not necess-
arily contingent on injection of active
agents into a tumour mass (Borsos and
Rapp, 1973; Schmidtke and Simmons,
1974). The findings certainly cast doubt
on any attempt to generalize to the
opposite effect-that local administration
ofnonspecific immunostimulators is neces-
sary from individual test models in
which such route of introduction has
seemed superior (Rapp, 1973).
It also appears from the results
described here that injection of placebo
(isotonic saline) into or adjacent to a
tumour can elicit effects sufficient to
obscure the therapeutic action of MER
and even ofx-irradiation in parallel experi-
mental groups. Such consequences of
treatment must be taken into account in
the design of all tumour immunotherapy
studies, and they may be indicative of
one of the mechanisms of nonspecifically
induced immunological intervention.
Damage to tissues, necrosis and inflam-
matory changes no matter how induced
can be envisaged to impinge on host
immunological reactivity in a variety of
ways, and directly on tumour cells in the
vicinity as " innocent bystanders " of
the event. It would appear probable
that both specific and truly nonspecific
reactions come into play in the stimulation
of immune responses against neoplastic
cells and a seemingly nonspecific immuno-
stimulator may be capable of eliciting a
variety of effects of immunological con-
sequence, especially when it is a complex
natural product. It would be dangerous
to conclude that the parameters govern-
ing the behaviour of any one such agent
against a given tumour represent the
conditions demanded for efficacy by all
similar agents against that tumour, or by
the same substance against other
neoplasms.
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